Harrow, Inc. (HROW) — Stock Score Summary

Harrow, Inc. (HROW) has a MoatMap StockRank of 22/100 based on Quality (44/100), Value (21/100), and Momentum (44/100) factor scores. The current signal is SELL. Harrow, Inc. in ophthalmology pharma lacks a clear macro tailwind for an asymmetric opportunity and has only an average quality score (Q: 57). The fund's philosophy demands more than just a 'fine' business; it requires a powerful macro tailwind for high conviction.

Harrow, Inc. is an ophthalmic pharmaceutical company focused on the development, production, and commercialization of a broad portfolio of branded and generic eye care products. The company leverages its vertically integrated capabilities, including sterile ophthalmic compounding, and an expanding commercial infrastructure to serve the specialized needs of the ophthalmic market.

Key Financial Metrics

Price$35.39
Market Cap$1.5B
P/E (Forward)12.77
Price/Book44.38
Return on Equity-35.4%
Return on Invested Capital7.5%
Debt/Equity1060.52
Gross Margin74.1%
Operating Margin-50.0%
Revenue Growth-7.6%
Free Cash Flow$-5M

Harrow, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Harrow, Inc.’s (HROW) StockRank?
MoatMap’s StockRank for Harrow, Inc. (HROW) is 22/100, with a Sell signal. It is a composite of Quality (44), Value (21), and Momentum (44) factor ranks across MoatMap’s 19,000+ stock universe.
Does Harrow, Inc. have an economic moat?
Harrow, Inc. (HROW) has a Quality factor score of 44/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Harrow, Inc. a buy, hold, or sell?
MoatMap’s current signal for Harrow, Inc. (HROW) is Sell, based on a StockRank of 22/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Harrow, Inc. in?
Harrow, Inc. (HROW) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksHROW deep dive reportAI ChampionsHow we score stocksSense-check another stock